13th Annual Workshop on Medical Innovation and Healthcare
Experts gathered at The University of ÓÅÃÛ´«Ã½ to discuss contemporary issues in medical and healthcare innovation.
Medical innovation is crucial for advancing healthcare systems, improving patient outcomes, and addressing global health challenges. By fostering collaboration between academia, industry and healthcare organisations, innovations in medical research and technology can lead to breakthroughs that save lives and enhance the quality of care worldwide.
The (MIOIR) at The University of ÓÅÃÛ´«Ã½ hosted the 13th Annual Workshop on Medical Innovation and Healthcare (WOMI) from 11 to 13 December 2024. This year’s event brought together 23 participants from several countries to discuss contemporary issues in medical and healthcare innovation.
WOMI is an international network of researchers dedicated to studying innovation, entrepreneurship, and the organisation of research and development within healthcare organisations, medical devices, pharmaceuticals, and broader life sciences. The annual workshop serves as a platform for the core group of researchers and invited guests to engage in in-depth discussions on early-stage work and key themes in the field. Themes included innovation dynamics, cross-organisational collaboration and entrepreneurial activities in life sciences.
This year’s conference was organised and chaired by Ronnie Ramlogan and Dimitri Gagliardi together with Professor Maureen McKelvey (University of Gothenburg). They invited discussions on various critical topics, including the adoption of AI in medicine, innovative business models for healthcare, and the integration of pharmacogenetics/genomics into the NHS and other health systems.
Reflecting on the event, Professor Maureen Mckelvey remarked:
This year’s workshop highlighted the critical role of collaboration across academic, clinical, and industrial sectors in driving forward impactful medical innovations.
A key takeaway from the event was the recognition of the challenges and opportunities in integrating advanced innovations, such as pharmacogenetics and AI, into healthcare systems. This aligns with the overarching goals of WOMI to advance research and policy insights through interdisciplinary collaboration.
The 2024 event was a collaboration between the ÓÅÃÛ´«Ã½ Institute of Innovation Research at The University of ÓÅÃÛ´«Ã½ and the University of Gothenburg’s U-GOT KIES Center.
It also received funding support from the project ‘The Organisation and Diffusion of Translational Research: Can Cardiovascular Medicine learn from Oncology? Case Studies of Pharmacogenomics in the NHS’ (ES/W011484/1) and Swedish Research Council, Professor McKelvey’s Distinguished Professor Programme (VR DNR 2017-03360) ‘Knowledge-intensive Entrepreneurial Ecosystems’.
To learn more about the WOMI community and its ongoing contributions to medical innovation, .